Management of a Patient with Suspected Medication-Related Osteonecrosis of the Jaw
A 72-year-old female presents with a non-healing extraction socket in the mandibular left molar region (#36) 6 weeks post-extraction. She has exposed bone, mild pain, and no signs of infection. Her medical history includes breast cancer with bone metastases, treated with intravenous zoledronic acid for 3 years and denosumab for 1 year. She also takes calcium and vitamin D. She is a non-smoker. Her oral hygiene is good. Radiograph shows a sequestrum but no fracture.
1. What is the diagnosis, and how would you manage this patient?
Read the worked answer
Diagnosis: Medication-related osteonecrosis of the jaw (MRONJ), stage 2 (exposed bone with pain and no infection).
Management:
- Conservative approach: Avoid invasive surgery. Provide gentle debridement of necrotic tissue, saline rinses, and antibiotics if secondary infection occurs (e.g., amoxicillin 500 mg q8h for 7 days).
- Pain control: NSAIDs or acetaminophen.
- Consultation: Coordinate with oncologist regarding ongoing antiresorptive therapy; consider drug holiday if systemic condition allows (but often continued for cancer).
- Oral hygiene: Maintain meticulous hygiene; use chlorhexidine rinse.
- Follow-up: Monitor every 4–8 weeks. If no improvement after 6 months, consider surgical debridement or resection, but only by experienced surgeon.
- Avoid ill-fitting dentures and trauma.
Rationale: MRONJ in cancer patients is often managed conservatively to prevent progression. Surgery is reserved for refractory cases.
2. What preventive strategies should have been considered before the extraction?
Read the worked answer
Preventive strategies:
- Pre-treatment dental evaluation: Before starting antiresorptive therapy, complete all necessary dental work (extractions, periodontal treatment) to minimize future invasive procedures.
- Risk assessment: For patients on IV bisphosphonates or denosumab, avoid elective extractions if possible; consider endodontic treatment instead.
- If extraction necessary: Minimize trauma, achieve primary closure, prescribe antibiotics prophylactically, and use chlorhexidine rinse.
- Patient education: Inform about MRONJ risk and importance of oral hygiene.
- Drug holiday: Not routinely recommended for cancer patients, but discuss with oncologist.
Rationale: Prevention is key; once MRONJ develops, management is challenging.